- Home
- COLL vs PLAY Comparison
COLL vs PLAY Comparison
Compare COLL & PLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- PLAY
- Stock Information
- Founded
- COLL 2002
- PLAY 1982
- Country
- COLL United States
- PLAY United States
- Employees
- COLL N/A
- PLAY 23420
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- PLAY Restaurants
- Sector
- COLL Health Care
- PLAY Consumer Discretionary
- Exchange
- COLL Nasdaq
- PLAY Nasdaq
- Market Cap
- COLL 958.8M
- PLAY 1.1B
- IPO Year
- COLL 2015
- PLAY 1995
- Fundamental
- Price
- COLL $30.35
- PLAY $34.55
- Analyst Decision
- COLL Strong Buy
- PLAY Hold
- Analyst Count
- COLL 4
- PLAY 8
- Target Price
- COLL $43.75
- PLAY $31.83
- AVG Volume (30 Days)
- COLL 283.6K
- PLAY 1.6M
- Earning Date
- COLL 08-07-2025
- PLAY 06-10-2025
- Dividend Yield
- COLL N/A
- PLAY N/A
- EPS Growth
- COLL N/A
- PLAY N/A
- EPS
- COLL 1.25
- PLAY 1.02
- Revenue
- COLL $664,283,000.00
- PLAY $2,112,300,000.00
- Revenue This Year
- COLL $20.04
- PLAY $3.62
- Revenue Next Year
- COLL $3.98
- PLAY $6.33
- P/E Ratio
- COLL $24.19
- PLAY $34.01
- Revenue Growth
- COLL 17.17
- PLAY N/A
- 52 Week Low
- COLL $23.23
- PLAY $15.08
- 52 Week High
- COLL $42.29
- PLAY $43.73
- Technical
- Relative Strength Index (RSI)
- COLL 54.25
- PLAY 73.82
- Support Level
- COLL $29.28
- PLAY $29.55
- Resistance Level
- COLL $30.83
- PLAY $32.02
- Average True Range (ATR)
- COLL 0.75
- PLAY 1.61
- MACD
- COLL -0.00
- PLAY 0.01
- Stochastic Oscillator
- COLL 51.63
- PLAY 83.61
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About PLAY Dave & Buster's Entertainment Inc.
Dave & Buster's Entertainment Inc owns and operates nearly a hundred entertainment and dining establishments in the United States where customers can eat, drink, play games, and watch televised sports. Each store offers a full menu of entries and appetizers, a complete selection of alcoholic and non-alcoholic beverages, and an extensive assortment of entertainment attractions centered around playing games and watching live sports and other televised events. It derives maximum revenue from Entertainment.